PPIDT00063
Drug Information
| Name | Basiliximab |
|---|---|
| Sequence | QLQQSGTVLARPGASVKMSCKASGYSFTRYWMHWIKQRPGQGLEWIGAIYPGNSDTSYNQKFEGKAKLTAVTSASTAYMELSSLTHEDSAVYYCSRDYGYYFDFWGQGTTLTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK |
| DrugBank_ID | DB00074 |
| Type | biotech |
| Indication | For prophylactic treatment of kidney transplant rejection |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| — | Intravenous |
20 mg
|
| Injection | Intravenous |
10 mg
|
| Injection, powder, for solution | Intravenous |
10 mg
|
| Injection, powder, for solution | Intravenous |
10 mg/2.5mL
|
| Injection, powder, for solution | Intravenous |
20 MG
|
| Injection, powder, for solution | Intravenous |
20 mg/5mL
|
| Injection, powder, for solution | Intravenous; Intravenous bolus |
20 MG
|
| Powder | — |
20 mg/1vial
|
| Powder, for solution | Intravenous |
20 mg / vial
|
| Solution | Parenteral |
20.00 mg
|
| Injection | Intravenous |
20 mg
|
| Injection, powder, lyophilized, for solution | Intravenous |
20 mg
|
| Injection, powder, lyophilized, for solution | Intravenous |
2000000 mg
|